Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009868
Filing Date
2017-05-09
Accepted
2017-05-09 16:16:41
Documents
62
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgnx-10q_20170331.htm 10-Q 1821258
2 EX-10.1 rgnx-ex101_117.htm EX-10.1 97146
3 EX-31.1 rgnx-ex311_120.htm EX-31.1 17034
4 EX-31.2 rgnx-ex312_118.htm EX-31.2 16862
5 EX-32.1 rgnx-ex321_119.htm EX-32.1 11293
  Complete submission text file 0001564590-17-009868.txt   6068908

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgnx-20170331.xml EX-101.INS 1242811
7 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20170331.xsd EX-101.SCH 39183
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgnx-20170331_cal.xml EX-101.CAL 46712
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgnx-20170331_def.xml EX-101.DEF 141104
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20170331_lab.xml EX-101.LAB 328331
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20170331_pre.xml EX-101.PRE 258265
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37553 | Film No.: 17826623
SIC: 2836 Biological Products, (No Diagnostic Substances)